Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-01

Clinical Trial Update: Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sitagliptin in older adults with Type 2 diabetes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2009-05-01